Opioid Use Disorder

Unveiling the depth and dimensions of Opioid Use Disorder (OUD), a gripping health crisis marked by a relentless compulsion for opioids that eclipses the everyday lives of millions globally.
Patient and doctor discussing CNS depressant treatment, specifically Xanax addiction treatment

Table of Contents

Primary Item (H2)
Jeremy Dubin
Clinically Reviewed By Dr. Jeremy Dubin

Opioid Use Disorder (OUD) is a complex and chronic brain disease characterized by the compulsive use of opioids, despite the detrimental consequences it brings to an individual's health, social life, and overall functioning. It is a condition that transcends physical dependence, embodying a pattern of behavior where the pursuit and consumption of opioids dominate an individual’s life.

OUD is not merely a physical dependence on opioids but a multifaceted disorder involving changes in the brain and behavior. The hallmark of this disorder is the persistent use of opioids, driven by changes in the brain's reward and regulatory systems, often leading to harmful outcomes. Individuals with OUD may experience intense cravings and find it challenging to control their opioid use, even when they are aware of the negative impacts.

Statistics & Public Health Impact

OUD represents a significant public health challenge, with millions affected globally. In the United States alone, recent data suggests that 1.6 million people were diagnosed with OUD in 2019, highlighting the pervasive nature of this crisis. Tragically, 68,630 opioid-overdose related deaths were reported nationally in 2020, with 80,411 reported in 2021, averaging around 220 deaths per day, a stark reminder of the disorder's severity and the urgency of addressing it.

The repercussions of OUD extend beyond the individual. It disrupts relationships, hinders performance in work or educational settings, and often results in legal and financial troubles. This broader impact underscores the need for a comprehensive approach to prevention, treatment, and support for those affected and their communities.

OUD as a Treatable Condition

Despite its challenges, OUD is treatable. A combination of medication and behavioral therapies has proven effective in helping individuals overcome opioid dependence. Treatments are designed not just to stop opioid use but also to support long-term recovery and improve quality of life. With the right intervention and support, individuals with OUD can embark on a journey to recovery and regain control over their lives.

Emphasis on Compassionate Care

Understanding OUD as a chronic brain disease necessitates a shift in perspective. It calls for compassionate care and a nuanced understanding of the disorder's nature. This approach not only helps in treating individuals effectively but also plays a crucial role in reducing the stigma associated with OUD, thus encouraging more people to seek help.

Opioids and How They Work

Opioids are a class of drugs renowned for their pain-relieving properties, derived from the opium poppy plant or synthesized in laboratories. They play a crucial role in medical practice, primarily used for pain management but also in treating coughs and diarrhea. However, their potent effects on the brain make them susceptible to misuse, leading to the risk of addiction, known as Opioid Use Disorder (OUD).

Types of Opioids

Opioids are a diverse group of substances known for their potent pain-relieving properties. They are categorized based on their origin—natural, semi-synthetic, and synthetic. Each type has unique characteristics and uses in medical practice. Here's a closer look at the different types of opioids:

Natural Opiates

Derived directly from the opium poppy plant, natural opiates are among the oldest pain relievers known to humanity. Common natural opiates include:

Morphine

Highly effective for severe pain; frequently used in hospital settings, especially post-surgery.

Codeine

Less potent than morphine, used for mild to moderate pain and often found in some prescription cough syrups.

Semi-synthetic Opioids

These are created in labs from natural opiates and are designed to provide pain relief with varying strengths and durations. Examples include:

Oxycodone

Found in medications like OxyContin and Percocet, used for managing moderate to severe pain.

Hydrocodone

Used in drugs like Vicodin, typically prescribed for moderate pain.

Hydromorphone

Known as Dilaudid, used for acute pain often in a clinical setting.

Buprenorphine

Used both for pain management and as a treatment for opioid use disorder.

Synthetic Opioids

These opioids are completely synthesized in labs and include some of the most potent painkillers used in medicine.

Fentanyl

Known for its extreme potency, it's used in severe pain management and anesthesia but also has a high potential for abuse.

Methadone

Often used in pain management and for the treatment of opioid addiction.

Tramadol

Considered less potent, it's prescribed for moderate pain.

Meperidine

AKA Demerol, used less frequently today due to its side effects but still effective for acute pain episodes

How Opioids Interact with the Brain and Body

Opioids exert their effect by binding to specific receptors in the brain, spinal cord, and other areas of the body. They block pain signals sent from the body through the spinal cord to the brain. This action not only diminishes the perception of pain but also can induce feelings of relaxation and euphoria.

The Reward Pathway and Addiction

The euphoric effects of opioids are due to their impact on the brain's reward system. They trigger the release of dopamine, a neurotransmitter associated with pleasure and satisfaction. This activation of the reward pathway can make opioids highly addictive for some individuals as the brain begins to associate opioid use with positive reinforcement.

Development of Tolerance and Dependence

With prolonged use, individuals may develop tolerance, necessitating higher doses to achieve the same pain relief or euphoric effect. This escalation can lead to physical dependence, where the body adapts to the drug's presence. If opioid use is reduced or stopped, withdrawal symptoms often occur, which can be physically and emotionally distressing, further complicating the cycle of addiction.

Distinguishing Physical Dependence from OUD

It's important to note that physical dependence on opioids, characterized by tolerance and withdrawal, is not synonymous with OUD. OUD involves a more complex pattern of behavior, where the pursuit and consumption of opioids negatively impact an individual's health and daily life.

The Opioid Crisis

The opioid crisis is a critical public health issue that has escalated into an epidemic, deeply affecting communities across the globe, particularly in the United States. It is characterized by widespread misuse of both prescription and non-prescription opioids, leading to a dramatic increase in opioid-related overdoses and deaths.

The Escalation of the Crisis

Rising Overdose Deaths: The crisis is marked by a staggering rise in overdose deaths. In recent years, the United States has seen an alarming increase in fatalities, with tens of thousands of lives lost annually to opioid overdoses. This trend reflects both the addictive nature of these substances and the growing prevalence of powerful synthetic opioids like fentanyl.
Public Health Emergency Declaration: In response to the escalating overdose rates, the U.S. declared the opioid crisis a nationwide Public Health Emergency. This declaration acknowledges the severity of the epidemic and mobilizes government resources and attention towards combating this crisis.

Factors Contributing to the Crisis

Prescription Practices: Initially fueled by over-prescribing and aggressive marketing of opioid pain relievers in the late 1990s, the crisis was born from a well-intentioned desire to manage pain but lacked adequate oversight regarding the addictive potential of these drugs.
Availability of Synthetic Opioids: The proliferation of synthetic opioids, such as fentanyl, which are far more potent than natural opioids, has exacerbated the crisis. Often used to lace other drugs unbeknownst to users, these substances have significantly increased the risk of fatal overdoses.
Socioeconomic and Psychological Factors: The crisis is also driven by broader socioeconomic and mental health issues. Factors like economic distress, lack of access to healthcare, and untreated mental health disorders contribute to the increased vulnerability to opioid misuse and addiction.

Impact on Society

Beyond Health Consequences: The opioid crisis has far-reaching implications beyond health. It strains healthcare systems, impacts law enforcement, and burdens the economy. It disrupts families and communities, contributing to a cycle of societal challenges.
Stigma and Barriers to Treatment: Stigma associated with addiction continues to be a significant barrier to seeking treatment. Public perception of OUD as a moral failing rather than a medical condition hinders effective response and support for affected individuals.

Public Health Response

Increased Access to Treatment: Efforts are being made to expand access to treatment, including medications for addiction treatment (MAT), which combine medications with counseling and behavioral therapies.
Prevention and Education: Preventive measures, such as educating healthcare providers and the public about the risks of opioid use and implementing prescription monitoring programs, are crucial.
Policy and Regulation Changes: Governments are enacting policies to regulate prescriptions, enhance pain management protocols, and facilitate safer prescribing practices.
Harm Reduction Strategies: Public health initiatives are also focusing on harm reduction strategies, like the distribution of naloxone, a medication that can rapidly reverse an opioid overdose, and supporting needle exchange programs to reduce the spread of infectious diseases.

OUD Screening Test

Identifying Opioid Use Disorder

Opioid Use Disorder (OUD) is a medical condition characterized by an impaired ability to stop or control opioid use despite the negative impact it has on one's life. It encompasses a range of behaviors, from misuse of prescribed opioids to dependency on illicit drugs like heroin.

Diagnostic Criteria

The diagnosis of OUD is based on criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). A diagnosis is considered when at least two of the following symptoms occur within a 12-month period:

Opioids are taken in larger amounts or over a longer period than intended.
Persistent desire or unsuccessful efforts to cut down or control opioid use.
A great deal of time is spent in activities necessary to obtain, use, or recover from the effects of opioids.
Cravings, or a strong desire or urge to use opioids.
Recurrent opioid use results in a failure to fulfill major role obligations at work, school, or home.
Continued opioid use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of opioids.
Cravings, or a strong desire or urge to use opioids.
Important social, occupational, or recreational activities are given up or reduced because of opioid use.
Recurrent opioid use in situations in which it is physically hazardous.
Opioid use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by opioids.
Tolerance, as defined by either of the following: a need for markedly increased amounts of opioids to achieve intoxication or desired effect; a markedly diminished effect with continued use of the same amount of an opioid.
Withdrawal, as manifested by either of the following: the characteristic opioid withdrawal syndrome; opioids are taken to relieve or avoid withdrawal symptoms.

Severity of OUD

The severity of OUD is gauged based on the number of criteria present:

Mild: Presence of 2-3 symptoms.
Moderate: Presence of 4-5 symptoms.
Severe: Presence of 6 or more symptoms.

Understanding Tolerance and Withdrawal

Tolerance refers to needing higher doses of opioids to achieve the same effect or feeling less effect with the same dose over time. Conversely, withdrawal symptoms may include nausea, muscle aching, fever, diarrhea, and insomnia, reflecting the body's physical dependence on the substance.

Distinction from Physical Dependence

It's important to distinguish OUD from physical dependence. Physical dependence on opioids can occur with long-term use, even if the medication is taken as prescribed. However, it doesn't necessarily mean that a person has OUD, which involves a pattern of compulsive use and a range of harmful consequences.

Risk Factors for Opioid Use Disorder

Opioid Use Disorder (OUD) does not arise from a single cause but is the result of a complex interplay of various factors. Understanding these risk factors can help in early identification and prevention efforts.

Genetic and Biological Factors

Genetic and biological factors play a significant role in the development of OUD. These include inherited traits and individual differences in brain chemistry that can influence how a person reacts to opioids.

  • Genetics: A family history of substance abuse can increase the likelihood of developing OUD. Research suggests that genetics may account for about 40-60% of the risk factors for addiction.
  • Brain Chemistry: Individuals may have variations in brain chemistry that make them more susceptible to the effects of opioids, including how they experience pain and pleasure.

Environmental and Social Influences

The environment in which an individual lives and the social interactions they have can significantly impact the likelihood of developing OUD. These factors often shape attitudes and behaviors toward drug use.

  • Early Exposure: Exposure to drug use in the family or social environment during childhood or adolescence can increase the risk of later substance abuse.
  • Peer Pressure: Social circles that encourage or normalize drug use can be a significant factor, especially among younger individuals.
  • Socioeconomic Factors: Poverty, unemployment, and living in an area with high drug availability can increase the risk of developing OUD.

Psychological and Emotional Health

Mental health and emotional well-being are deeply intertwined with the risk of developing OUD. Psychological factors can both predispose individuals to addiction and result from the challenges of managing chronic pain or mental health conditions.

  • Mental Health Disorders: There is a strong correlation between mental health disorders, such as depression, anxiety, PTSD, and the development of substance use disorders, including OUD.
  • Trauma: Experiences of trauma, particularly in childhood, such as abuse or neglect, can lead to coping mechanisms that include substance misuse.

Medical and Prescription History

Medical history, especially related to pain management, and the way opioids are prescribed play a significant role in the risk of developing OUD. This includes both the length of time and the dosage of opioid prescriptions.

  • Chronic Pain: Patients with chronic pain conditions may be prescribed opioid painkillers, increasing their risk of dependency.
  • Prescription Practices: Over-prescription or inadequate monitoring of opioid prescriptions can lead to the development of OUD.
  • Previous Substance Use: A history of substance use or misuse increases the likelihood of developing OUD.

Behavioral Aspects

Individual behavior and lifestyle choices can also influence the risk of developing OUD. This includes patterns of behavior that may predispose an individual to substance misuse.

  • Risk-Taking Behavior: Individuals who have a tendency towards risk-taking or thrill-seeking behaviors may be more prone to experimenting with drugs, including opioids.
  • Stressful Life Events: People undergoing significant life stressors or transitions may turn to opioids as a coping mechanism.

Opioid Withdrawal Syndrome & Symptoms of Opioid Withdrawal

Opioid Withdrawal Syndrome is a significant and challenging aspect of Opioid Use Disorder (OUD). It occurs when a person who has become physically dependent on opioids either reduces their opioid use or stops taking them altogether. Understanding the symptoms and management of opioid withdrawal is crucial for both individuals undergoing withdrawal and healthcare providers managing their treatment.

Understanding Opioid Withdrawal Syndrome

Opioid Withdrawal Syndrome is the body's response to the absence of opioids after a period of regular use. This response is due to physical dependence, where the body adapts to the presence of opioids and experiences a range of symptoms when the opioids are no longer present.

Symptoms of Opioid Withdrawal

Opioid withdrawal symptoms can range from mild to severe, depending on factors such as the duration of opioid use, the type of opioid used, and the individual’s physical health. Symptoms typically begin within a few hours to a few days after discontinuing or reducing opioid use and include:

Physical Symptoms

Muscle aches and pains
Restlessness and agitation
Insomnia
Diarrhea and abdominal cramping
Nausea and vomiting
Sweating
Fever
Dilated pupils and possibly blurry vision

Psychological Symptoms

Anxiety and nervousness
Depression
Irritability
Strong cravings for opioids

Timeline of Opioid Withdrawal

The experience of opioid withdrawal can vary significantly from person to person, and the timeline is influenced by factors such as the specific opioid used, the duration and intensity of use, individual physiology, and overall health. It is important to note that withdrawal timelines can change.

The induction process into treatment can range from 24 hours to more. Some people are candidates for low-dose induction, and some for high-dose induction. Again, this is dependent on the person and the substance they are using. Here is a general outline of the typical timeline for opioid withdrawal:

Early Stages 

(6-12 Hours for Short-Acting Opioids, 12-48 Hours for Long-Acting Opioids)

The onset of withdrawal symptoms usually begins within hours after the last dose. For short-acting opioids like heroin, symptoms can start as early as 6-12 hours after the last use. For longer-acting opioids like methadone, symptoms may not appear until 12-48 hours after the last dose.
Initial symptoms are often mild and include muscle aches, anxiety, and an increased desire for the drug.

Peak Symptoms

(24-72 Hours)

Symptoms typically peak within 1 to 3 days and can be quite severe. This period is often the most uncomfortable for the individual.
Common symptoms during this phase include intense drug cravings, nausea, vomiting, diarrhea, sweating, tremors, rapid heartbeat, and high blood pressure.
Psychological symptoms like anxiety, irritability, and insomnia are also heightened during this phase.

Subsiding Phase

(1 Week and Beyond)

After the peak, physical symptoms gradually begin to subside over the course of a week. However, some symptoms, like nausea and diarrhea, may persist for a bit longer.
Psychological symptoms and cravings can continue beyond the physical symptoms, sometimes lasting for weeks or months. This period requires ongoing support and treatment, as the risk of relapse is high.
Post-acute withdrawal symptoms (PAWS), such as ongoing mood swings, anxiety, and disturbed sleep patterns, can persist for several months, though they typically decrease in intensity over time.

Importance of Supervised Withdrawal

Due to the intense nature of some withdrawal symptoms and the potential for complications, medically supervised withdrawal (detoxification) is highly recommended. Supervision ensures that individuals are safe, their symptoms are managed effectively, and they have support through the psychological aspects of withdrawal.

Medical supervision also paves the way for a smoother transition into long-term treatment and recovery programs, which are crucial for sustainable recovery from OUD.

Treatment and Management of OUD

The treatment and management of Opioid Use Disorder (OUD) are multifaceted, involving a combination of medication, behavioral therapy, and continuous care. Successful treatment typically requires a personalized approach, addressing not only the addiction itself but also any associated psychological, social, and health issues.

Medications for Addiction Treatment (MAT)

Medications for Addiction Treatment (MAT) combines FDA-approved medications with counseling and behavioral therapies to treat OUD. These medications help alleviate withdrawal symptoms and reduce cravings, making it easier for patients to engage in therapy and recovery.

  • Methadone: A long-acting opioid that reduces cravings and withdrawal symptoms. It is dispensed daily under supervision at specialized clinics.
  • Buprenorphine: Partially activates opioid receptors, helping to reduce cravings and withdrawal symptoms. It can be prescribed in an office setting, increasing accessibility.
  • Naltrexone: Blocks opioid receptors, preventing opioids from producing euphoric effects. It is available in pill form or as a monthly injection.

Behavioral Therapies

Behavioral therapies are key components of OUD treatment, focusing on changing drug use behaviors through counseling and other therapy techniques. These approaches help patients develop skills to manage their addiction and modify attitudes and behaviors related to drug abuse.

  • Cognitive Behavioral Therapy (CBT): CBT helps patients recognize and change thinking and behavior patterns related to drug use.
  • Contingency Management: Contingency Management provides tangible rewards for positive behaviors such as staying drug-free.
  • Motivational Interviewing: Motivational Interviewing builds motivation and commitment to change harmful behaviors associated with drug use.
  • Family Therapy: Family Therapy involves family members in the treatment process to support recovery and address any family-related issues.

Supportive Care and Recovery Services

Supportive care and recovery services are vital in providing the necessary social and emotional support. These services promote long-term recovery and help individuals reintegrate into their communities successfully.

  • Peer Support Groups: Groups like Narcotics Anonymous provide a supportive community for individuals in recovery.
  • Counseling Services: Ongoing counseling helps address the emotional and psychological aspects of addiction.
  • Treatment for Co-Occurring Disorders: Addressing mental health disorders that often coexist with OUD is crucial for successful treatment.

Long-term Management

Long-term management of OUD involves ongoing care and support. It focuses on maintaining abstinence, preventing relapse, and sustaining the recovery journey over a lifetime.

  • Continuous Monitoring and Adjustment: Treatment plans should be regularly reviewed and adjusted as needed.
  • Relapse Prevention: Education on coping strategies and triggers is essential to prevent relapse.
  • Aftercare Planning: Ongoing support following formal treatment helps maintain long-term recovery.

Holistic and Integrative Approaches

A holistic approach to OUD treatment recognizes the importance of treating the whole person, not just the addiction. It includes strategies to improve overall health and well-being.

  • Pain Management Alternatives: Non-opioid pain management strategies are important for patients with chronic pain.
  • Lifestyle Modifications: Encouraging healthy habits, like exercise and nutrition, can support overall well-being and recovery.
  • Complementary Therapies: Practices such as meditation, yoga, and acupuncture may be helpful as adjunctive treatments.

Special Considerations in OUD Treatment

Treating Opioid Use Disorder (OUD) effectively often requires adapting to the unique circumstances and needs of different patient groups. These special considerations are essential to provide personalized and effective care.

Treatment for Pregnant Women

Treating OUD in pregnant women demands a careful balance between managing the disorder and ensuring the safety of both the mother and the developing fetus. This includes choosing appropriate medications and monitoring for complications.

  • Safety for Mother and Child: Pregnant women with OUD require treatments that are safe for both them and the developing fetus. Controlling withdrawal symptoms during pregnancy are very important medically for both mom and baby. Methadone and buprenorphine are commonly used as they are safer alternatives compared to illicit opioid use.
  • Management of Neonatal Opioid Withdrawal Syndrome (NOWS): Infants born to mothers with OUD may experience withdrawal symptoms, requiring specialized care and treatment.

Co-Occurring Mental Health Disorders

Individuals with OUD often face co-occurring mental health disorders, necessitating an integrated approach to treatment that addresses both sets of conditions in a coordinated manner.

  • Integrated Treatment Approach: Many individuals with OUD also suffer from mental health disorders. Integrated treatment plans that address both OUD and co-occurring mental health conditions simultaneously are essential for effective treatment.
  • Adjustment of Medications: Medications for mental health conditions and OUD need to be carefully managed to avoid interactions and ensure effectiveness.

Adolescents and Young Adults

Young individuals with OUD require specialized treatment approaches that are tailored to their age and developmental stage, often involving family support and engagement.

  • Tailored Therapeutic Approaches: Treatment approaches for younger individuals should be age-appropriate and consider the unique developmental challenges faced by adolescents and young adults.
  • Family Involvement: Engaging the family in the treatment process, providing additional support, and addressing family dynamics is often beneficial for younger patients.

Patients with Chronic Pain

For patients with chronic pain who have a history of OUD, treatment strategies must prioritize effective pain management while minimizing the risk of relapse into opioid misuse.

  • Non-Opioid Pain Management: For patients with chronic pain, non-opioid pain management strategies are crucial to prevent the recurrence of OUD.
  • Monitoring and Adjustments: Ongoing monitoring of pain management strategies is essential to ensure they are effective and do not contribute to a relapse of OUD.

Poly-Substance Use

Treating patients with poly-substance use involves a comprehensive approach that addresses all aspects of their substance use to ensure a holistic recovery.

  • Comprehensive Substance Use Assessment: Individuals who use multiple substances require a thorough assessment to develop an effective treatment plan.
  • Addressing All Substance Use Disorders: Treatment should address all forms of substance use, not just OUD, to ensure a holistic approach to recovery.

Cultural and Social Factors

A patient's cultural background and social circumstances play a significant role in treatment outcomes, requiring culturally sensitive and socially informed treatment approaches.

  • Culturally Sensitive Approaches: Understanding and respecting the patient’s cultural background can enhance the effectiveness of treatment and improve engagement.
  • Addressing Social Determinants of Health: Factors such as housing, employment, and social support play a significant role in the success of treatment and should be addressed as part of the care plan.

Helping a Loved One with Opioid Use Disorder

Supporting a loved one who is struggling with Opioid Use Disorder (OUD) can be a challenging yet crucial part of their journey to recovery. The first step in providing effective support is recognizing the signs of opioid misuse, which may include behavioral changes, social withdrawal, neglect of responsibilities, or physical symptoms like drowsiness or altered sleep patterns. It's also important to be alert to mood shifts, health issues, financial troubles, or legal complications that might signal a problem with opioid use.

When approaching a loved one about their opioid use, it's essential to communicate openly and compassionately. Initiating a non-confrontational conversation and expressing your concerns without judgment or blame can encourage them to open up about their struggles. At the same time, educating yourself about OUD is vital. Understanding the disorder, its symptoms, and treatment options allows you to provide informed support and be aware of various recovery programs, including Medications for Addiction Treatment (MAT), counseling, and support groups.

Encouraging your loved one to seek professional help is a critical step. Offer your assistance in researching treatment options and facilitate making appointments or providing transportation if necessary. Emotional and practical support is also incredibly valuable. Being there to listen, offering encouragement, and assisting with practical needs such as childcare or transportation can significantly alleviate the burden on someone grappling with OUD.

Setting healthy boundaries is essential for both your well-being and that of your loved one. Clearly communicate behaviors you cannot tolerate and ensure you take care of your own mental and emotional health, perhaps by seeking support for yourself through counseling or support groups. Recovery is a long-term process and may include setbacks. Being patient and understanding, staying informed about their recovery process, and offering ongoing support are key to helping your loved one navigate this journey.

It's crucial to understand that relapse can be part of the recovery process and does not signify failure. If a relapse occurs, encourage your loved one to continue their treatment and remind them that recovery is still within reach. Your support can make a significant difference in their journey towards overcoming OUD.

Porch Light Health Can Help

For those grappling with Opioid Use Disorder (OUD), finding the right support and treatment is crucial for the journey towards recovery. Porch Light Health stands out as a beacon of hope and assistance in this challenging journey. With over 60 care locations spread throughout Colorado and New Mexico, Porch Light Health offers comprehensive care and support to individuals struggling with OUD.

Porch Light Health specializes in providing Medications for Addiction Treatment (MAT), an evidence-based approach that combines medication with counseling and behavioral therapies to treat substance use disorders. This integrative treatment model is designed to address the whole person, not just the addiction, ensuring a more sustainable path to recovery.

In addition to MAT, Porch Light Health offers a range of behavioral and psychiatric care services. Understanding that OUD often coexists with other mental health issues, the clinic's approach to care includes addressing these co-occurring disorders. This holistic treatment strategy enhances the effectiveness of OUD treatment and supports overall mental and emotional well-being.

Porch Light Health is committed to offering accessible, compassionate, and personalized care. Our team of dedicated professionals understands the complexities of OUD and works closely with each individual to develop a tailored treatment plan that meets their specific needs.

If you or a loved one is struggling with Opioid Use Disorder, Porch Light Health is here to help. Reach out to take the first step towards recovery and healing. Their extensive network of care locations and comprehensive treatment options provide a solid foundation for overcoming addiction and reclaiming control of your life.  Register as a new patient today.

Sources

Opioid use disorder. (n.d.). https://www.psychiatry.org/patients-families/opioid-use-disorder

SAMHSA, Center for Behavioral Health Statistics and Quality. (n.d.). Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health. https://www.samhsa.gov/data/sites/default/files/reports/rpt29393/2019NSDUHFFRPDFWHTML/2019NSDUHFFR090120.htm

Drug overdose death rates | National Institute on Drug Abuse. (2023, September 25). National Institute on Drug Abuse. https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates

Opioid Use Disorder: Preventing and treating | Healthcare professionals | Opioids | CDC. (n.d.). https://www.cdc.gov/opioids/healthcare-professionals/prescribing/opioid-use-disorder.html

National Library of Medicine. (n.d.). Opioids and Opioid Use Disorder (OUD). https://medlineplus.gov/opioidsandopioidusedisorderoud.html

Mind matters: The body’s response to opioids | National Institute on Drug Abuse. (2022, June 13). National Institute on Drug Abuse. https://nida.nih.gov/research-topics/parents-educators/lesson-plans/mind-matters/opioids

Kosten, T. R., & George, T. P. (2002). The Neurobiology of Opioid dependence: Implications for treatment. Science & Practice Perspectives, 1(1), 13–20. https://doi.org/10.1151/spp021113

Understanding the opioid overdose epidemic | Opioids | CDC. (n.d.). https://www.cdc.gov/opioids/basics/epidemic.html

Opioid crisis: Status of public health emergency authorities. (n.d.). U.S. GAO. https://www.gao.gov/products/gao-18-685r

Hirsch, R. (2017, April 1). The opioid epidemic: It’s time to place blame where it belongs. PubMed Central (PMC). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140023/

Fentanyl | Opioids | CDC. (n.d.). https://www.cdc.gov/opioids/basics/fentanyl.html

Walden University. (2022, October 22). Opioid crisis: the strain it places on the healthcare system. Walden University. https://www.waldenu.edu/online-masters-programs/master-of-healthcare-administration/resource/opioid-crisis-the-strain-it-places-on-the-healthcare-system

Assistant Secretary for Public Affairs (ASPA). (2022, November 29). Harm reduction. Overdose Prevention Strategy. https://www.hhs.gov/overdose-prevention/harm-reduction

IT Matters Colorado | DSM-5 Criteria for Diagnosis of Opioid Use Disorder. https://www.asam.org/docs/default-source/education-docs/dsm-5-dx-oud-8-28-2017.pdf

Berrettini, W. H. (2017). A brief review of the genetics and pharmacogenetics of opioid use disorders. Dialogues in Clinical Neuroscience, 19(3), 229–236. https://doi.org/10.31887/dcns.2017.19.3/wberrettini

Kosten, T. R., & George, T. P. (2002). The Neurobiology of Opioid dependence: Implications for treatment. Science & Practice Perspectives, 1(1), 13–20. https://doi.org/10.1151/spp021113

Mennis, J., Stahler, G. J., & Mason, M. (2016). Risky Substance Use Environments and Addiction: A New Frontier for Environmental Justice research. International Journal of Environmental Research and Public Health, 13(6), 607. https://doi.org/10.3390/ijerph13060607

Opioid Use Among Individuals with Posttraumatic Stress Disorder.  PTSD Research Quarterly. National Center for PTSD. Vol. 30/No. 1. 2019.  https://www.ptsd.va.gov/publications/rq_docs/V30N1.pdf

Santo, T., Campbell, G., Gisev, N., & Degenhardt, L. (2022). Exposure to childhood trauma increases risk of opioid use disorder among people prescribed opioids for chronic non-cancer pain. Drug and Alcohol Dependence, 230, 109199. https://doi.org/10.1016/j.drugalcdep.2021.109199

Volkow, N. D., & McLellan, A. T. (2016). Opioid abuse in chronic pain — Misconceptions and mitigation strategies. The New England Journal of Medicine, 374(13), 1253–1263. https://doi.org/10.1056/nejmra1507771

Shah, M. (2023, July 21). Opioid withdrawal. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK526012/

Case-Lo, C. (2023, November 27). Withdrawing from Opiates and Opioids. Healthline. https://www.healthline.com/health/opiate-withdrawal

Katie E. Golden, MD. (2023). GoodRX - Opioid Withdrawal: Typical Timeline and Common Symptoms (n.d.-b). https://www.goodrx.com/conditions/opioid-use-disorder/how-long-opioid-withdrawal-symptoms-last

Post-Acute Withdrawal Syndrome (PAWS) | Semel Institute for Neuroscience and Human Behavior. (n.d.). https://www.semel.ucla.edu/dual-diagnosis-program/News_and_Resources/PAWS

Methadone. (2023, September 18). https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/methadone

Buprenorphine. (2023, September 18). https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/buprenorphine

Naltrexone. (2023, September 18). https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/naltrexone

Carley, J. A., & Oesterle, T. (2021). Therapeutic Approaches to Opioid Use Disorder: What is the Current Standard of Care? International Journal of General Medicine, Volume 14, 2305–2311. https://doi.org/10.2147/ijgm.s295461

  1. (n.d.). https://na.org/

Guenzel, N. (2023, July 21). Addiction relapse prevention. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK551500/

Dey, S. (2023, July 21). Alternatives to opioids for managing pain. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK574543/

Opioid Use Disorder and Pregnancy | CDC. (2022, November 15). Centers for Disease Control and Prevention. https://www.cdc.gov/pregnancy/opioids/treatment.html

Weller, A. E., Crist, R. C., Reiner, B. C., Doyle, G. A., & Berrettini, W. H. (2020). Neonatal Opioid Withdrawal Syndrome (NOWS): a transgenerational echo of the opioid crisis. Cold Spring Harbor Perspectives in Medicine, 11(3), a039669. https://doi.org/10.1101/cshperspect.a039669

Jones, C. M., & McCance‐Katz, E. F. (2019). Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug and Alcohol Dependence, 197, 78–82. https://doi.org/10.1016/j.drugalcdep.2018.12.030

St Marie, B., & Broglio, K. (2020). Managing pain in the setting of opioid use disorder. Pain Management Nursing, 21(1), 26–34. https://doi.org/10.1016/j.pmn.2019.08.003

Polysubstance use facts. (n.d.). https://www.cdc.gov/stopoverdose/polysubstance-use/index.html

Populations Who We Serve

At Porch Light Health, we understand that each stage of life presents unique challenges and opportunities for growth. Our comprehensive services are tailored to meet the diverse needs of individuals across different age groups.

Teens

Guide your teen through the challenges of substance use and peer pressure with dedicated programs that foster healthy choices and resilience.
Find Out More

Adults

Address substance use and addiction in adulthood with personalized treatment plans that promote recovery and long-term wellness.
Find Out More

Seniors

Support seniors dealing with addiction or medication management with specialized care that prioritizes safety, respect, and recovery.
Find Out More
At Porch Light Health, we recognize the unique challenges faced by various communities. Our inclusive approach ensures that every individual feels supported and understood. Explore our dedicated services that affirm and assist every member of our community.
Suboxone® is a registered trademark of Indivior UK Limited. Porch Light is not affiliated with Indivior UK Limited or its affiliates ("Indivior"), and any reference to it or its intellectual property is for informational purposes only and is not endorsed or sponsored by Indivior.
2025 © Porch Light Health. All Rights Reserved
Privacy PolicySitemap
Translate »